Cannabinoid therapy helps provide effective relief for cancer patients with pain that responded poorly to opioids, according to results of a trial reported in The Journal of Pain. In the randomized ...

BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer ...

Kazmira Pharmacy is the first licensed 503A compounding pharmacy in the country offering THC-free, prescription-only CBD.

Case report shows clinical benefits of Argent’s CannEpil in a paediatric patient with Lennox-Gastaut Syndrome Peer-reviewed case report published in International Journal of Clinical Medicine & Case ...

Alzheimer’s disease has long resisted simple solutions, but a new line of research suggests an unexpected pairing could help keep the condition at bay: a marijuana-derived compound working alongside a ...

New research suggests THC’s cognitive drawbacks may be mitigated when combined with a targeted anti-inflammatory drug. Cannabis research has highlighted a scientific paradox. Its best-known ...

In recent years, the pharmaceutical landscape has witnessed a seismic shift as cannabinoids transition from niche alternatives to mainstream medical solutions. The days of skepticism surrounding ...

Friday, SciSparc Ltd. (NASDAQ:SPRC) signed an exclusive patent license agreement with Polyrizon Ltd to out-license its SCI-160 program to treat pain. According to the License Agreement, Polyrizon will ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. The Devon company's stock surged 36 percent after initial ...

CNW/ - MTL Cannabis Corp. (CSE: MTLC) (OTCQX: MTLNF) ("MTL Cannabis" or the "Company") is pleased to announce that the ...